Investor Relations

Latest Financial Results

Q1 2021

Quarter Ended Mar 31, 2021

Latest Annual Filing

Fiscal Year Ended Dec 31, 2020

View Filing

Stock Information

Company Overview

Ocuphire Pharma is a clinical-stage ophthalmic biopharmaceutical company focused on developing and commercializing therapies for the treatment of several eye disorders.

Download VEGA-1 TopLine Data Results Conference Call Presentation

Investor Contact Information


Ocuphire Pharma, Inc.
37000 Grand River Ave., Suite 120
Farmington Hills, MI 48335
T: 248-681-9815

Investor Relations

LifeSci Advisors
250 West 55th Street, Suite 3401
New York, NY 10019
T: 646-889-1200

Transfer Agent

American Stock Transfer & Trust Company LLC
6201 15th Avenue
Brooklyn, NY 11219
T: 800-937-5449